Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule

The clinical efficacy of antiangiogenic small molecules (e.g., sunitinib) in breast carcinoma has largely failed with substantial off-target toxicity. We rationally designed and evaluated preclinically a novel sunitinib analogue, SAP, with favourable pharmacological properties and the ability to be...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Argyros, Orestis, Karampelas, Theodoros, Varela, Aimilia, Asvos, Xenophon, Papakyriakou, Athanasios, Agalou, Adamantia, Beis, Dimitris, Davos, Constantinos H., Fokas, Demosthenes, Tamvakopoulos, Constantin
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2017
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5514907/
https://ncbi.nlm.nih.gov/pubmed/28422745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16763
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍